Fresenius Medical Care, a Germany-based dialysis provider, said its acquisition of rival Renal Care Group, Nashville, could be delayed until 2006 because it's still responding to Federal Trade Commission requests for additional information regarding antitrust issues. Fresenius still hopes it can close the deal before the end of 2005, which has been the goal since the $3.5 billion deal was announced in May, company officials said. The FTC made a second request for information in June and Fresenius shareholders approved the acquisition in August. If the deal is approved, Fresenius would be the largest provider of dialysis services, adding 450 clinics to the 1,155 that it owns in North America and providing services at another 210 U.S. hospitals. Fresenius also announced that its net income was $339 million on revenue of $5 billion for the first nine months of 2005, compared with net income of $294 million on revenue $4.6 billion through the first nine months of 2004. -- by Joseph Mantone
Fresenius' acquisition of Renal Care could be delayed
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.